China urges companies to ensure COVID-related medical supplies
BEIJING, Dec 15 (Reuters) - China has urged state-backed
pharmaceuticals giants to ensure provision of COVID-related
medical supplies, the country's state asset regulator said on
Thursday.
The companies include China Resources, China General
Technology and Sinopharm, which own businesses that produce
medications that could ease coronavirus symptoms.
(Reporting by Ella Cao and Meg Shen
Editing by David Goodman)
((Ella.Cao@thomsonreuters.com;))
Recent news on China Resources Medical Holdings
See all newsBrief: China Resources Medical To Pay Final Dividend Of RMB8.4 Cents Per Share
Brief: China Resources Medical Expects FY Profit Attributable Of RMB467 MLN To RMB516 MLN
Brief: China Resources Medical Announces Resignation Of Yang Min As Executive Director And CFO
Brief: China Resources Medical Appoints Zhang Chuang As CEO & Executive Director
Brief: China Resources Medical Says Shan Baojie Resigns As Executive Director